The Efficacy of Pain Management With Self-reporting Pain Monitoring System in Cancer Patient

The Efficacy of Pain Management With Self-reporting Pain Monitoring

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03117075

Acronym

pain

Enrollment

Registered

2017-04-17

Start date

2017-05-15

Completion date

2018-04-14

Last updated

2017-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

cancer pain, wearable device

Brief summary

To compare the pain scales between clinician evaluated and reported with wearable device by patients.

Detailed description

To compare the pain scales between clinician evaluated and reported with wearable device by patients with cancer of advanced stage.

Interventions

DEVICEusing device for scoring pain scale, named ANAPA®

wearable device for scoring pain scale

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* over 20 year old * cancer pain with visual analog scale or numeric rating scale score \>/- 4 * opioids candidates * with informed consent form

Exclusion criteria

* life expectancy within 3 months

Design outcomes

Primary

Measure	Time frame	Description
Actual difference of pain scales	1 week after using wearable pain scale device - baseline and 1 week.	comparing the pain scale assessed by wearable device and that assessed by physician when out patient clinic.

Countries

South Korea

Contacts

Primary ContactDERSHENG SUN, MD, PhD

ds-sun@hanmail.net+82-31-820-3584

Backup ContactHYESUNG WON, MD, PhD

woncomet@catholic.ac.kr+82-31-820-5247

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026